Rodríguez RT, Solís Marquínez MN, Álvarez MDCC, Fernández Suárez J, Fernández Domínguez J, Rodríguez BI, Rodríguez Álvarez FJ. Clostridium paraputrificum bacteremia in a 64-year-old woman with colon carcinoma.
Anaerobe 2023;
81:102716. [PMID:
36774980 DOI:
10.1016/j.anaerobe.2023.102716]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2022] [Revised: 01/18/2023] [Accepted: 02/09/2023] [Indexed: 02/12/2023]
Abstract
Here we report a case of bacteremia caused by Clostridium paraputrificum in a 64-year-old woman with colon carcinoma and gastrointestinal disease. Using the new EUCAST 2022 clinical breakpoints [1] for Clostridium perfringens, the isolate was susceptible to metronidazole and vancomycin, but resistant to benzylpenicillin, meropenem, and clindamycin. Thus, treatment with metronidazole should be considered in all patients with Clostridium bacteremia until antibiotic susceptibility is determined to minimize the risk of treatment failure.
Collapse